Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001677036-26-000006

Options or other derivatives

  • Director acquired 1,105 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lind Kevin Robert · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-30 Grant or award : show line 1 in the form Stock Option (Right to Buy) +1,105 $15.04 $16,619 1,105 D
Loading xslF345X06/form4-07022026_040719.xml…